These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35699895)

  • 1. Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.
    Mehra Y; Rajesh NG; Viswanathan P
    Probiotics Antimicrob Proteins; 2022 Oct; 14(5):854-872. PubMed ID: 35699895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-quality whole-genome sequence analysis of Lactobacillus paragasseri UBLG-36 reveals oxalate-degrading potential of the strain.
    Mehra Y; Viswanathan P
    PLoS One; 2021; 16(11):e0260116. PubMed ID: 34797858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats.
    Sasikumar P; Gomathi S; Anbazhagan K; Abhishek A; Paul E; Vasudevan V; Sasikumar S; Selvam GS
    J Biomed Sci; 2014 Aug; 21(1):86. PubMed ID: 25175550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of oxalyl-CoA decarboxylase (oxc) and formyl-CoA transferase (frc) genes in novel probiotic isolates capable of oxalate degradation in vitro.
    Youssef HIA
    Folia Microbiol (Praha); 2024 Apr; 69(2):423-432. PubMed ID: 38217756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy.
    Afkari R; Feizabadi MM; Ansari-Moghadam A; Safari T; Bokaeian M
    Int Braz J Urol; 2019; 45(6):1249-1259. PubMed ID: 31808414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
    Mogna L; Pane M; Nicola S; Raiteri E
    J Clin Gastroenterol; 2014; 48 Suppl 1():S91-5. PubMed ID: 25291139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR; Reid SJ
    Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
    Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
    Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
    Giardina S; Scilironi C; Michelotti A; Samuele A; Borella F; Daglia M; Marzatico F
    J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus.
    Azcarate-Peril MA; Bruno-Bárcena JM; Hassan HM; Klaenhammer TR
    Appl Environ Microbiol; 2006 Mar; 72(3):1891-9. PubMed ID: 16517636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney.
    Bijarnia RK; Kaur T; Aggarwal K; Singla SK; Tandon C
    Food Chem Toxicol; 2008 Jun; 46(6):2274-8. PubMed ID: 18423961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of hyperoxaluria-induced kidney dysfunction by chemical chaperone 4-phenylbutyric acid.
    Randhawa R; Bhardwaj R; Kaur T
    Urolithiasis; 2019 Apr; 47(2):171-179. PubMed ID: 29947992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity of probiotics-oxalate degradation.
    Murphy C; Murphy S; O'Brien F; O'Donoghue M; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
    Vet Microbiol; 2009 Apr; 136(1-2):100-7. PubMed ID: 19028028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC; Goldfarb DS; De Simone C; Regnier C
    Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR; Glenton PA; Byer KJ
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
    Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
    Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.